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INTRODUCTION
Allergic rhinitis results from specific IgE-mediated allergic re-
actions in the nasal mucosa, characterized by a runny nose, na-
sal itching, sneezing, and nasal congestion. Nasal biopsy reveals 
accumulations of mast cells, eosinophils, and basophils in the 
submucosal layer and accumulations of eosinophils in the lam-
ina propria.
1 Treatment of allergic rhinitis has generally focused 
on suppressing these inflammatory reactions, and the main 
medications used are antihistamines, nasal steroids, and leu-
kotriene receptor antagonists. Apart from these treatments, im-
munotherapy can be performed in some patients.
2 In cases of 
perennial allergic rhinitis, the symptoms are often prolonged 
for extended periods of time and thus require long-term medi-
cation. However, antihistamines can be ineffective against na-
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sal congestion, the most common symptom, and long-term use 
can lead to weight gain in some patients. Thus, patients who do 
not want to receive such long-term medication often seek com-
plementary and alternative therapies the effects of which have 
not yet been verified.
Ginseng has long been used as an herbal medication through-
out East Asia, including Korea, and is a member of the scientific 
family Araliaceae, genus Panax. Of the species of ginseng, the 
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Purpose:  Allergic rhinitis is clinically defined as a disorder of the nose induced by IgE mediated inflammation after allergen exposure of the nasal 
mucosa. Many reports have stated that Panax ginseng and fermented red ginseng have anti-inflammatory effects, especially against Th2-type inflam-
mation. This study was conducted to evaluate the therapeutic effects of fermented red ginseng in allergic rhinitis.  Methods:  In this 4-week, dou-
ble-blind, placebo-controlled study, 59 patients with persistent perennial allergic rhinitis were randomly divided into two groups: those receiving fer-
mented red ginseng tablets (experimental group) and those receiving placebo (control group). The primary efficacy variable was the total nasal symp-
tom score (TNSS; rhinorrhea, sneezing, itchy nose, and nasal congestion). Secondary efficacy variables were the Rhinitis Quality of Life (RQoL) score 
and skin reactivity to inhalant allergens, as determined by the skin prick test.  Results:  There was no significant difference in the TNSS score and 
TNSS duration score between the experimental and placebo groups in weeks 1, 2, 3, or 4. For nasal congestion, fermented red ginseng was signifi-
cantly effective (P<0.005), while placebo caused no change. The activity and emotion of RQoL improved markedly secondary to treatment with fer-
mented red ginseng (P<0.05), while placebo caused no change. Additionally, fermented red ginseng reduced skin reactivity to sensitized perennial 
allergens (P<0.05). Fermented red ginseng was well tolerated.  Conclusions:  Fermented red ginseng improved nasal congestion symptoms and 
RQoL in patients with perennial allergic rhinitis.
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four most commonly used for medicinal purposes are Panax 
ginseng, P. japonicum, P. notoginseng, and P. quinquefolium; the 
term “ginseng” generally refers to P. ginseng.
3 Commercialized 
ginseng is broadly categorized into three types depending on its 
age and manufacturing process: fresh ginseng that is less than 4 
years old and has not been dried, white ginseng that is 4-6 years 
old and has been peeled or either sun-dried or oven-dried, and 
red ginseng that is older than 6 years and steamed before being 
dried. The specific drying process of red ginseng leads to a non-
enzymatic color change that gives it its characteristic hue. These 
various methods of preparing ginseng alter the formation and 
concentration of the saponin within the ginseng.
4,5 Fermented 
red ginseng has been treated with microorganisms and en-
zymes that enhance the saponin content of the red ginseng for 
maximum efficacy; this is based on the fact that ginseng’s effi-
cacy in different subjects varies based on the number and ac-
tivity of each individual’s intestinal flora. Several studies have 
reported ginseng’s effect in increasing immunity and exerting 
an anti-inflammatory effect.
6,7 Hyun et al.
8 reported that red 
ginseng and fermented red ginseng had a much greater effect 
in suppressing allergic inflammation than did white ginseng.
Thus, the purpose of this study was to analyze whether fer-
mented red ginseng results in clinically significant symptomat-
ic improvement in patients with allergic rhinitis.
MATERIALS AND METHODS
Patients
This study included patients aged 18-55 years who had been 
continuously experiencing allergic rhinitis symptoms for at 
least 2 years, whose skin prick test result was positive for more 
than one perennial allergen (house dust mites, fungi, cockroach-
es, or animal hair), and who had experienced at least two of the 
four major symptoms: itching, sneezing, runny nose, and con-
gestion, with a minimum symptom score of 2 points. The fol-
lowing patients were excluded from the study: (1) those who 
were taking medication for allergic diseases, (2) those who had 
taken antihistamines or H2-blockers within 2 weeks of the study, 
(3) those who had asthma, hypertension, or diabetes mellitus, 
(4) those who were pregnant or who might become pregnant 
within 3 months of the study, and (5) those who showed abnor-
mal results in blood tests prior to the study.
Materials
Our study utilized soft capsules (250 mg/capsule) that were 
made from fermented red ginseng (FRG). FRG powder was 
provided by Bifido Inc. (Hongcheon, Korea). The dried FRG 
contained 236.7 mg crude saponin, 2.3 mg Rb2, 0.1 mg Rb3, 0.6 
mg Rc, 9.5 mg Rd, 0.5 mg Re, 0.6 mg Rg1, 8.2 mg Rg2, 27.7 mg 
Rg3, 12.1 mg Rh1, 3.1 mg Rh2, and 61.0 mg compound K per 
gram. The placebo capsules were the same size and shape and 
were filled with starch.
Study design
Our randomized, double-blind, placebo-controlled study was 
approved by the Institutional Review Board of Seoul National 
University Hospital and was conducted between September 28 
and November 23, 2009 (H-008-042-290). Patients who met our 
inclusion criteria and did not fall into any exclusion criteria were 
randomly placed into the experimental group, who received 
fermented red ginseng capsules, or the control group, who re-
ceived placebo capsules. All patients were instructed to take 
three capsules two times daily for 4 weeks. A Rhinitis Quality of 
Life (RQoL) survey was performed directly before and after the 
4-week treatment period, and the total nasal symptom score 
(TNSS) was also recorded daily throughout the treatment peri-
od.
Skin prick test
Each patient underwent a skin prick test for 14 allergens (Ben-
card, Bretford, UK), including house dust mites (Dermatopha-
goides pteronyssinus and D. farinae), fungi (Alternaria spp., 
Cladosporium spp., and Aspergillus spp.), cockroaches, and an-
imal hair (dog and cat fur) as perennial allergens, and trees (tree 
mixture and hazel), grass (grass mixture and orchard grass), 
and weeds (mugwort and ragweed) as seasonal allergens. We 
used a saline solution as a negative control and histamine as a 
positive control (1 mg/mL). We measured the skin reaction 15 
minutes after application of the allergens; an allergen wheal 
that had a size ratio greater than 1 when compared with a hista-
mine wheal was considered to be a positive reaction.
Efficacy measurements
Changes in the TNSS of each patient were considered the pri-
mary efficacy variable, and changes in the RQoL and skin prick 
test were considered secondary efficacy variables. The TNSS 
evaluates symptoms of itching, sneezing, runny nose, and con-
gestion on a four-point scale: 0=no symptoms, 1=mild sym-
ptom(s) (present but bearable), 2=moderate symptom(s) (pres-
ent and uncomfortable), and 3=severe symptom(s) (unbear-
able). The symptoms were further scored based on their dura-
tion per day: 0=none, 1=less than 30 minutes, 2=between 30 
minutes and 2 hours, and 3=longer than 2 hours.
9,10 The TNSS 
values were averaged on a weekly basis during the study and 
compared with the TNSS values from before the study (week 0) 
to determine whether there were differences between them. 
The mean TNSS score and mean change in TNSS were described 
as averages of the four TNSS items and changes. The RQoL 
evaluated quality of life on a five-point scale in 28 items that 
could broadly be divided into seven domains: practical prob-
lems, sleep, nasal symptoms, non-nose/non-eye symptoms, 
activity state, emotional state, and eye symptoms.
11 RQoL scores 
were taken and compared before (week 0) and after the study 
and were evaluated for statistical significance. The sizes of the 
wheals and flares in the skin prick tests from before and after Fermented Red Ginseng in Allergic Rhinitis AAIR 
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the study were taken and compared.
Safety evaluation
Before and after the study, we conducted numerous blood 
tests to check for adverse reactions, and all patients were re-
quested to immediately contact us if they noticed any kind of 
adverse reaction.
Statistical analyses
The sample size was calculated on the basis of a previous 
study
12 that compared the efficacy of montelukast versus mon-
telukast-levocetirizine for the treatment of persistent allergic 
rhinitis. Assuming a mean baseline TNSS of 7.95 and standard 
deviation of 0.68, it was estimated that a sample size of 23 pa-
tients in each active group would provide 80% power to show a 
statistically significant difference between the two treatments at 
a 0.05 significance level. The sample size of each group was then 
determined to be 33 patients, allowing a 30% dropout rate.
All statistical analyses were performed using the SPSS software 
(ver. 16.0, SPSS Inc., Chicago, IL, USA), and values are present-
ed as means±standard errors. Variables were evaluated using 
Fischer’s exact test and the Mann-Whitney U-test. The before 
and after comparisons of the TNSS, RQoL, and skin test results 
were analyzed with the paired t-test. A P value of <0.05 was con-
sidered to indicate statistical significance.
RESULTS
Patient characteristics
In total, 66 patients were enrolled in this randomized, double-
blind, placebo-controlled clinical trial, and seven did not com-
plete the study because they withdrew their consent. Thus, in 
total, 59 patients completed the study; 30 were randomly placed 
in the experimental group, and 29 were placed in the control 
group.
The age of the patients ranged from 19 to 48 years (mean, 26.6 
years). There were 21 male patients, and they made up 35.6% of 
the participants. The mean number of positive reactions to all 
allergens was 2.64±0.20, and that to perennial allergens was 
2.05±0.10. The mean numbers of positive reactions to all and 
perennial allergens were not significantly different between the 
two groups. There were no significant differences between the 
two groups in age, gender, underlying diseases, or serum total 
IgE at the time of the first visit. The mean TNSS score, mean 
TNSS duration score, and RQoL were not significantly different 
between the two groups (Table 1).
Efficacy assessment of primary variables
There was no significant difference in TNSS score or TNSS du-
ration score between the experimental and placebo groups in 
weeks 0 and 4 (Table 2). However, both groups showed an im-
provement in TNSS over time. When the symptoms were sepa-
rately assessed as itching, runny nose, sneezing, and nasal con-
gestion, there was similar improvement over time for the first 
three symptoms. However, for nasal congestion, the experimen-
tal group showed a significantly greater improvement in the 
TNSS in weeks 2, 3, and 4, but the control group did not (Fig. 1). 
For the four major symptoms, there was a similar reduction in 
symptom duration over the course of the study. However, for 
nasal congestion, the symptom duration was significantly re-
duced in week 4 in the control group, whereas it was significant-
ly reduced from week 1 in the experimental group (Fig. 2). Based 
on this result, it was determined that fermented red ginseng 
had an early effect on nasal congestion. There were similar 
trends in runny nose and sneezing symptoms as well, with the 
control group showing improvements in weeks 2 and 3 and the 
experimental group showed improvement from week 1.
Efficacy assessment of secondary variables
When comparing RQoL scores between before and after the 
4-week medication, both the experimental and control groups 
Table 1.  Demographic characteristics of the study population
Fermented red 
ginseng group 
(n=30) 
Placebo group 
(n=29) P value
* 
Sex
Male (%) 12 (40.0)  10 (34.5)  NS 
Female (%) 18 (60.0)  19 (65.5) 
Age (yr)  25.77±1.08  27.07±1.19  NS 
Underlying diseases
Atopic dermatitis (%) 2 (6.7)  5 (17.2)  NS 
Chronic urticaria (%) 3 (10.0)  0 (0.0)  NS 
Food allergy (%) 4 (13.3)  2 (6.9)  NS 
Acute gastritis (%) 3 (10.0)  2 (6.9)  NS 
Atopic index 
  (for perennial allergens) 
2.20±0.14  1.90±0.13  NS 
Serum total IgE (U/mL) 536.15±58.83  507.38±45.67  NS 
Baseline symptom 
Mean TNSS score  1.84±0.10  1.97±0.10  NS 
Itchy nose 1.53±0.18  1.86±0.15  NS 
Nasal congestion 1.83±0.17  1.93±0.16  NS 
Runny nose 2.13±0.12  2.17±0.16  NS 
Sneezing 1.87±0.16  1.93±0.16  NS 
Mean TNSS duration score 2.04±0.12  1.97±0.10  NS 
Itchy nose 1.63±0.20  1.83±0.17  NS 
Nasal congestion 2.20±0.19  2.24±0.18  NS 
Runny nose 2.37±0.14  2.07±0.17  NS 
Sneezing 1.97±0.15  1.59±0.17  NS 
Overall RQoL score 11.79±2.25  11.80±3.08  NS 
*Analyzed by Fischer’s exact test and the Mann-Whitney U-test.
NS, not significant; TNSS, total nasal symptom score; RQoL, Rhinitis Quality of 
Life.Jung et al.
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showed an improvement over the course of the study. Howev-
er, the control group did not show a significant improvement in 
activity or emotional state, whereas the experimental group 
showed significant improvements (Fig. 3).
In the skin prick test performed before the 4-week medica-
tion, there was no significant difference in skin reactions to his-
tamine between the two groups. However, in the skin prick test 
performed after the 4-week medication, the experimental group 
showed smaller wheal and flare sizes to histamine than the 
control group. The experimental group also showed a signifi-
cant reduction in mean wheal sizes for the eight perennial al-
lergens tested, whereas the control group did not (Fig. 4).
Serum total IgE levels
When total IgE levels from before and after the 4-week medi-
cation were compared, the control group showed a significant 
increase, whereas the experimental group did not (Table 2).
Safety assessment
Of the 59 patients, three developed mild hepatic dysfunction 
as an adverse reaction. Of those three patients, one in the ex-
perimental group showed an increase in alanine aminotrans-
ferase (ALT) (27 vs. 42 IU/L), but further examination 2 weeks 
later showed that ALT had returned to normal. In the other two 
patients, who were both in the control group, one developed an 
Table 2.  Mean TNSS score, mean TNSS duration score, overall RQoL score, and total IgE (U/mL) from baseline to week 4
Fermented red ginseng group Placebo group
P value
† 
Week 0 Week 4 Diff. P value* Week 0 Week 4 Diff. P value*
Mean TNSS score  1.84±0.53 1.16±0.55 0.69±0.63 <0.0001 1.97±0.56 1.46±0.75 0.52±0.77 0.001 NS
Mean TNSS duration score 2.04±0.67 1.22±0.54 0.82±0.76 <0.0001 1.93±0.59 1.42±0.76 0.51±0.87 0.004 NS
Overall RQoL score 11.79±2.25 9.38±2.45 2.40±2.35 <0.0001 11.80±3.08 10.14±3.34 1.66±2.81 0.004 NS
Total IgE 536.15±58.83 538.73±58.08 2.58±5.64 NS 507.38±45.67 522.34±50.75 14.96±6.27 0.025 NS
*Analyzed by the paired t-test. 
†Analyzed by the Mann-Whitney U-test.
TNSS, total nasal symptom score; RQoL, Rhinitis Quality of Life; Diff., difference between weeks 0 and 4; NS, not significant.
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Fig. 1.  Weekly improvement from baseline to week 1, 2, 3, and 4 in the total nasal symptom score (TNSS). (A) Mean TNSS score, (B) itchy nose, (C) nasal conges-
tion, (D) runny nose, and (E) sneezing score.
*P<0.05, vs. baseline, analyzed by the paired t-test.
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increase in total bilirubin (1.0 vs. 1.5 mg/mL), and one showed 
an increase in ALT (36 vs. 43 IU/L). There was no other report of 
adverse reactions, and there was no significant difference be-
tween the two groups in reported adverse reactions.
 
DISCUSSION
Allergic rhinitis, an allergic inflammatory disease of the nasal 
airway, causes a variety of chronic symptoms that continuously 
fluctuate in severity over time, causing discomfort and a decrease 
in quality of life. Thus, early symptomatic treatment through in-
flammation control is important. Because of the chronic nature 
of allergic inflammation, some patients are reluctant to take 
long-term medication and so turn to unverified alternative med-
ications. Alternative medicine is used by approximately 80% of 
the world’s population. The United States spends roughly $34 
billion annually on alternative medicine.
13 A previous study 
documented that Germany alone spends roughly €90 million 
on alternative treatments for allergic diseases, including bron-
chial asthma.
14 However, because the majority of these alterna-
tive treatments have not been medically evaluated, they often 
lead to symptom aggravation, adverse effects, and the inability 
to complete regular medical treatments; the medical costs as-
sociated with these problems are not trivial. Many of these al-
ternative treatments are in need of experimental and clinical 
evaluation.
Some of the “health foods” that are currently being studied for 
their effects on allergic rhinitis include probiotics,
15 spirulina,
16 
and extracts from green tea, guajava leaves, and rose petals.
17 In 
fact, many current medications for the treatment of allergic rhi-
nitis are derived from the plants and substances used in alter-
native medicine. For example, ephedrine came from the ephe-
dra plant, anticholinergics were developed from henbane leaves, 
theophylline was taken from tea tree leaves, and cromolyn came 
from Ammi visnaga.
18
It is believed that when a substance isolated from fermented 
red ginseng is effective in treating allergic diseases, it can be re-
produced for medication. Various studies have indicated that 
ginseng has anti-inflammatory and anti-allergenic effects. Gin-
seng induces vasodilation and reduces platelet aggregation, 
thus improving cardiovascular function, has antioxidant and 
hypoglycemic properties, and stimulates the immune system 
Fig. 2.  Weekly improvement from baseline to week 1, 2, 3, and 4 in the total nasal symptom score (TNSS) symptom duration score. (A) Mean TNSS duration score, 
(B) itchy nose, (C) nasal congestion, (D) runny nose, and (E) sneezing score.
*P<0.05, vs. baseline, analyzed by the paired t-test. 
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through activation of the pituitary-adrenal axis.
19 Ginseng can 
alter blood adrenocorticotropic hormone and corticosterone 
levels,
20,21 and ginseng’s saponin components, Rb1 and Rg1, are 
ginsenosides that act as ligands for glucocorticoid receptors, 
thus inducing glucocorticoid activity.
22 Ligor et al.
23 indicated 
that ginsenoside reverses the dexamethasone-induced down-
regulation of glucocorticoid receptors and that it has pharma-
cological activities similar to those of glucocorticoids. When 
ginseng root extracts are administered to mice, the production 
of anti-allergic cytokines, such as IFN-γ and IL-10, is increased; 
additionally, RANTES (Regulated on Activation, Normal T-cell 
Expressed and Secreted) synthesis and secretions of IL-4, IL-5, 
and IL-12, which provoke allergic inflammation, are sup-
pressed.
24 Bae et al.
6 reported that administration of the ginsen-
oside Rb1 metabolite compound K to mice had the effect of 
suppressing passive cutaneous anaphylaxis caused by IgE-anti-
gen complexes. The reduction of IL-4 and TNF-α manifestation 
and suppression of NF-κB and CCL7 (C-C motif) ligand 7 activ-
ities have been proposed as its mechanism.
6 Additionally, Babay-
igit et al.
7 demonstrated that when ginseng extract is adminis-
tered in a murine asthma model, chronic airway remodeling is 
prevented compared with the placebo group; further, because 
the degree of airway remodeling was similar to that in the dexa-
methasone group, ginseng was considered to be as effective as 
steroids for asthma treatment. From these results, it is conceiv-
able that ginseng increases the Th1 response and suppresses 
Fig. 3.  Change in mean value from baseline to week 4 in overall Rhinitis Quality of Life (RQoL) score and individual RQoL domain scores.
*P<0.05, vs. baseline, analyzed by the paired t-test.
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the Th2 response, thus reducing or preventing allergic inflam-
mation.
It is known that during ginseng processing, ginseng, red gin-
seng, and fermented red ginseng contain different composi-
tions of ginsenosides, which lead to their differences in anti-in-
flammatory properties.
16 Red ginseng and fermented red gin-
seng are more effective than white ginseng at suppressing the 
transcription of NF-κB and subsequent synthesis of proinflam-
matory cytokines, such as TNF-α and IFN-γ, as well as synthe-
sizing nitric oxide induced by lipopolysaccharides.
16 Jeong et 
al.
25 reported that in a murine asthma model, red ginseng de-
creased airway resistance as well as the total cell count and 
number of eosinophils in the bronchoalveolar lavage fluid.
In this study, nasal congestion was significantly improved in 
the experimental group. Nasal congestion is related to both an 
acute allergic inflammation of mast cells and chronic inflam-
mation. The therapeutic effect of antihistamines, which are 
generally effective on mast cells, on nasal congestion has been 
unclear. Furthermore, the use of nasal decongestants may wors-
en symptoms through a rebound phenomenon when the use 
of the medication is stopped. Nasal topical steroids, while effec-
tive in reducing nasal congestion through their anti-inflamma-
tory effects, are associated with many adverse reactions when 
used for long periods of time, such as nasal mucosal atrophy, 
nasal pain, epistaxis, and nasal septal perforation; thus, they re-
quire special precautions in their application. Therefore, it was 
expected that consistent ingestion of fermented red ginseng 
may allow patients with chronic allergic rhinitis to reduce nasal 
congestion without steroid therapy. Allergic rhinitis does not 
merely cause nasal discomfort due to persistent nasal symp-
toms, but also leads to losses in concentration and headaches, 
which can affect sleep, social interaction, school work, and even 
workplace productivity, leading to socioeconomic losses.
26 While 
the control group showed an improvement in TNSS after the 
4-week medication, their emotional and activity states were un-
affected, whereas the experimental group showed not only a 
reduction in nasal symptoms but also significant improvement 
in emotional and activity states after the 4-week medication. 
From this result, it was found that fermented red ginseng can 
not only serve to reduce symptoms in patients with allergic rhi-
nitis, but also improve their quality of life.
In the skin prick test, the experimental group showed a reduc-
tion in the size of wheals and flares to histamine and showed a 
smaller wheal size to perennial allergens than did the control 
group. This led us to conclude that fermented red ginseng has 
an effect on allergic inflammatory reactions to both histamine 
and specific allergens. Our results suggest a similar mechanism 
to the passive cutaneous anaphylaxis reaction reported in a 
previous animal study.
6 IgE plays an important role in the initi-
ation of allergic inflammatory reactions. In our study, the con-
trol group showed an increase in total IgE, whereas the experi-
mental group did not. Based on this result, it is thought that fer-
mented red ginseng has a potential anti-IgE effect.
In this study, there was no remarkable adverse effect, aggrava-
tion of symptoms, or significant abnormality in the results of 
routine blood tests. Thus, we are led to conclude that ferment-
ed red ginseng can be used to treat allergic rhinitis without any 
remarkable adverse effects.
Because this was a relatively small-scale, short-term study, 
further large-scale, long-term studies are needed to fully evalu-
ate the safety and efficacy of fermented red ginseng. Addition-
ally, comparisons with other nonmedical allergic rhinitis treat-
ments may be necessary. Another limitation of our study is that 
we relied on patient-reported symptom scores and quality of 
life surveys, and were unable to use measurements of nasal re-
sistance or nasal secretion smear tests for objective analyses.
In conclusion, the results of this study suggest that fermented 
red ginseng can be safely used as a health food to treat allergic 
rhinitis, can improve both nasal symptoms and overall quality 
of life, and has potential for further development.
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